Perspective Therapeutics, Inc. (CATX)
3.16
+0.05
(+1.61%)
USD |
NYAM |
Aug 31, 16:00
3.20
+0.04
(+1.27%)
After-Hours: 07:17
Perspective Therapeutics Total Long Term Debt (Quarterly) : 2.866M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.866M |
| March 31, 2026 | 3.162M |
| December 31, 2025 | 2.63M |
| September 30, 2025 | 2.609M |
| June 30, 2025 | 2.722M |
| March 31, 2025 | 2.838M |
| December 31, 2024 | 3.105M |
| September 30, 2024 | 3.365M |
| June 30, 2024 | 3.155M |
| March 31, 2024 | 2.75M |
| September 30, 2023 | 3.013M |
| June 30, 2023 | 2.315M |
| March 31, 2023 | 1.837M |
| June 30, 2022 | 0.256M |
| March 31, 2022 | 0.324M |
| December 31, 2021 | 0.392M |
| September 30, 2021 | 0.459M |
| June 30, 2021 | 0.524M |
| March 31, 2021 | 0.589M |
| December 31, 2020 | 0.652M |
| September 30, 2020 | 0.715M |
| June 30, 2020 | 0.769M |
| March 31, 2020 | 0.83M |
| December 31, 2019 | 0.889M |
| September 30, 2019 | 0.948M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 23.32M |
| MiMedx Group, Inc. | 17.21M |
| ABVC BioPharma, Inc. | 1.406M |
| Enovis Corp. | 1.344B |
| Edwards Lifesciences Corp. | 680.30M |